Zeeknil Pharmaceuticals Private Limited
About Zeeknil Pharmaceuticals Private Limited
Data last updated:
Zeeknil Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24230RJ2020PTC072713.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Prateek Jain and Shazia Naqvi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Imli Wala Phatak Near Bansal Hospital Kidwai Nagar Gandhi Nagar Jaipur, Rajasthan, India – 302015.
As per the financials filed for FY 2025, the company reported a revenue of ₹12,082, a decline of 88% compared to the previous year. For the same year it recorded a net profit of ₹4,182 (net margin 34.6%) and EBITDA of ₹4,182 (EBITDA margin 34.6%). Revenue has declined at a compounded annual rate (CAGR) of 63% over three years.
Company details
Contact details
Zeeknil Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan.
- Registered Address1 Imli Wala Phatak Near Bansal Hospital Kidwai Nagar Gandhi Nagar Jaipur, Rajasthan, India – 302015
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zeeknil Pharmaceuticals Private Limited
FY 2025 filings availableZeeknil Pharmaceuticals Private Limited reported revenue of ₹12,082 (down 88% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 63% over three years, including a 88% fall in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,182 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,182 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34.6% | ||||
| Net Profit Margin | 34.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zeeknil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zeeknil Pharmaceuticals Private Limited
Zeeknil Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prateek Jain | Director | 24 Dec 2020 | 5 Years 10 Months | Current |
| Shazia Naqvi | Director | 24 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Zeeknil Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alkerms Pharmaceuticals Private Limited | ₹12,690 (FY 2025) | -90.0% | New Delhi, Delhi, India | |||
| Calzone Pharmaceuticals Private Limited | ₹12,500 (FY 2025) | Ghaziabad, Uttar Pradesh, India | ||||
| Aarti Pharmaceuticals Private Limited | ₹12,211 (FY 2025) | New Delhi, Delhi, India | ||||
| Star Beta Pharmaceuticals Private Limited | ₹12,200 (FY 2025) | Varanasi, Uttar Pradesh, India | ||||
| Giva Pharmaceuticals Private Limited | ₹12,120 (FY 2020) | Sultanpur, Uttar Pradesh, India | ||||
| Zeeknil Pharmaceuticals Private Limitedthis company | ₹12,082 (FY 2025) | ₹4,182 | 34.6% | -88.0% | Jaipur, Rajasthan, India | |
| Andyeo Pharmaceuticals P Ltd | ₹12,000 (FY 2016) | Haryana, India | ||||
| Inomed Pharmaceuticals Private Limited | ₹12,000 (FY 2025) | Delhi, India | ||||
| Hekakare Pharmaceuticals Private Limited | ₹12,000 (FY 2025) | New Delhi, Delhi, India | ||||
| Ishir Pharmaceuticals Private Limited | ₹12,000 (FY 2023) | 76.0% | New Delhi, Delhi, India | |||
| Ramgyan Pharmaceuticals Private Limited | ₹11,500 (FY 2024) | Delhi, India |
To see the full peer comparison of Zeeknil Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zeeknil Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zeeknil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zeeknil Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zeeknil Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Swapnil Dangayach ceased to be Director on 19 Mar 2021.
Frequently asked questions
Zeeknil Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 24 December 2020 (6+ years old) and is registered under CIN U24230RJ2020PTC072713.
Zeeknil Pharmaceuticals has 2 current directors:
- Prateek Jain - Director
- Shazia Naqvi - Director
The latest financial statements of Zeeknil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Zeeknil Pharmaceuticals is U24230RJ2020PTC072713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zeeknil Pharmaceuticals was incorporated on 24 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Zeeknil Pharmaceuticals by revenue are Alkerms Pharmaceuticals Private Limited, Calzone Pharmaceuticals Private Limited, Aarti Pharmaceuticals Private Limited, Star Beta Pharmaceuticals Private Limited, Giva Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Swapnil Dangayach ceased to be Director on 19 Mar 2021. Prateek Jain was appointed as Director on 24 Dec 2020. Shazia Naqvi was appointed as Director on 24 Dec 2020.
The registered office of Zeeknil Pharmaceuticals is at 1 Imli Wala Phatak Near Bansal Hospital Kidwai Nagar Gandhi Nagar Jaipur, Rajasthan, India – 302015.
Zeeknil Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Zeeknil Pharmaceuticals can be reached at its registered office: 1 Imli Wala Phatak Near Bansal Hospital Kidwai Nagar Gandhi Nagar Jaipur, Rajasthan, India – 302015.
Zeeknil Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Jaipur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
